Drug Monitoring Assess Panel, Volatiles, Urine
*Build Your Own Panel Eligible [?]
|
$327
|
|
|
Description:
Ethanol is the most commonly abused substance whose primary effect on the central nervous system varies with blood concentration. Not all individuals experience the same effects at a given blood level. Additionally, other central nervous system depressants can have an additive effect when taken in combination with ethanol. Approximately 5% of ethanol is excreted unchanged in urine. A positive urine ethanol result may suggest recent ethanol exposure and/or consumption; however, in diabetic patients with a urinary tract infection, ethanol is commonly present in urine as a result of glucose fermentation by yeast in the urine. When fermentation is not suspected, and urine ethanol is adjusted by a sample's creatinine concentration, urine ethanol may be used to estimate blood ethanol concentrations, as urine ethanol concentrations are approximately 130% of blood concentrations, if the patient is in the elimination phase. Caution should be exercised with interpretation of urine ethanol results; it is not recommended that a clinical decision be based solely on a urine ethanol result as there are several different scenarios that may have yielded the result.
Categories:
Price:
$327
|
|
Drug Monitoring, Barbiturates, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
The barbiturate class of drugs are substances that are traditionally classified as sedatives. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. They are central nervous system (CNS) depressants. The test is a definitive assay using gas chromatography mass spectroscopy (GC/MS) methodology. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Barbiturates, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The barbiturate class of drugs are traditionally classified as sedatives and central nervous system depressants. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Barbiturates, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The barbiturate class of drugs are traditionally classified as sedatives and central nervous system depressants. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Base Panel, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$453
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$453
|
|
Drug Monitoring, Base Panel, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$453
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$453
|
|
Drug Monitoring, Benzodiazepines, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
The benzodiazepine class of drugs are traditionally classified as depressants. They are used therapeutically to produce sedation, induce sleep, relieve anxiety, treat muscle spasms, and to prevent seizures. In general, benzodiazepines act as hypnotics in high doses, anxiolytics in moderate doses, and sedatives in low doses. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the benzodiazepines is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Benzodiazepines, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The benzodiazepine class of drugs are traditionally classified as depressants. They are used therapeutically to produce sedation, induce sleep, relieve anxiety, treat muscle spasms, and to prevent seizures. In general, benzodiazepines act as hypnotics in high doses, anxiolytics in moderate doses, and sedatives in low doses. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of the benzodiazepines is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Benzodiazepines, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The benzodiazepine class of drugs are traditionally classified as depressants. They are used therapeutically to produce sedation, induce sleep, relieve anxiety, treat muscle spasms, and to prevent seizures. In general, benzodiazepines act as hypnotics in high doses, anxiolytics in moderate doses, and sedatives in low doses. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the benzodiazepines is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Buprenorphine and Naloxone, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
This test measures levels of buprenorphine and its metabolite norbuprenorphine in urine. Buprenorphine and norbuprenorphine are biomarkers for monitoring possible use or non-use of buprenorphine. The test is a definitive drug assay using the liquid chromatography/mass spectrometry (LC/MS-MS) method of analysis. Buprenorphine is an opioid analgesic used for moderate to moderately severe pain. Formulated with naloxone, buprenorphine is used to treat opioid substance use disorders. Less than 11% of the dose is excreted as free and conjugated unchanged drug, while less than 14% is excreted as free and conjugated metabolites [1]. According to the American Association for Clinical Chemistry (AACC), testing drugs/drug metabolites is recommended and effective for detecting the use of relevant over-the-counter, prescribed, and nonprescribed drugs, as well as illicit substances in pain-management patients [2]. Laboratory testing is more effective than other physician tools for the detection of these substances and is useful for routine monitoring of adherence. Instances where unchanged drug is detected, but metabolite(s) is not, may be indicative of drug added to the specimen after collection (eg, pill shaving, drug spiking) [2]. Note: No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as quantitative values and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose because the drug is extensively metabolized and excreted in the urine. References 1. Suboxoneยฎ [package insert]. Vacaville, CA: ALZA Corp; 2018. 2. AACC. Using clinical laboratory tests to monitor drug therapy in pain management patients. November 2017. https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Pain-Management/LMPGPain-Management20171220.pdf. Accessed November 21, 2019.
Categories:
Price:
$326
|
|
Drug Monitoring, Buprenorphine, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Buprenorphine is used for treatment of chronic pain in non-opioid tolerant individuals and has found a significant role in treatment of addiction to other opiates. The test is a screening assay using cloned enzyme donor immunoassay (CEDIA) method of analysis. Therapeutic urine drug monitoring of buprenorphine (and its major metabolite, norbuprenorphine) is important for ensuring compliance to treatment strategies as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking buprenorphine. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Buprenorphine, with Confirmation, includes Naloxone, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Patients treated with buprenorphine-naloxone co-formulation will demonstrate both naloxone and buprenorphine/norbuprenorphine drug analysis. Naloxone is not detected with buprenorphine-only use.
Categories:
Price:
$446
|
|
Drug Monitoring, Carisoprodol Metabolite, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Carisoprodol is used clinically as a muscle relaxant and sedative. Carisoprodol's metabolite, Meprobamate, is commonly accepted as the primary urinary metabolite in man. Detection of this metabolite is indicative of ingestion of carisoprodol. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of propoxyphene is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Cocaine Metabolite, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Cocaine is sometimes used clinically as a local anesthetic. More commonly however, it is used illicitly. Identification and verification of cocaine's metabolite benzoylecgonine in urine is most often used to show illicit use. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the cocaine is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Cocaine Metabolite, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Cocaine is sometimes used clinically as a local anesthetic. More commonly however, it is used illicitly. Identification and verification of cocaine's metabolite benzoylecgonine in urine is most often used to show illicit use. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of the cocaine is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Cocaine Metabolite, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Cocaine is sometimes used clinically as a local anesthetic. More commonly however, it is used illicitly. Identification and verification of cocaine's metabolite benzoylecgonine in urine is most often used to show illicit use. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the cocaine is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Designer Benzodiazepines, Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$322
|
|
|
Description:
Designer Benzodiazepines are compounds designed to mimic the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. They are a part of a class of drugs known as Novel Psychoactive Substances (NPS). NPS can also be referred to as legal highs, spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. Individuals may be exposed to illicit fentanyl or analogs, designer opoids, stimulants, and benzodiazepines, or xylazine, knowingly, or unknowingly through counterfeit prescription drugs intended to mimic common drugs such as oxycodone, hydrocodone, and alprazolam, among others. Updates and enhancements to our tested drug list are made from time to time based on surveillance data from the Center for Forensic Science Research and Education (CFSRE) and clinical patient trends. A complete and up to date list of the analytes contained in each drug class can be found at the bottom of each report and in our online FAQ.
Categories:
Price:
$322
|
|
Drug Monitoring, Designer Fentanyl Analogs, Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$322
|
|
|
Description:
Designer Fentanyl Analogs are compounds designed to mimic the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. They are a part of a class of drugs known as Novel Psychoactive Substances (NPS). NPS can also be referred to as legal highs, spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. Individuals may be exposed to illicit fentanyl or analogs, designer opoids, stimulants, and benzodiazepines, or xylazine, knowingly, or unknowingly through counterfeit prescription drugs intended to mimic common drugs such as oxycodone, hydrocodone, and alprazolam, among others. Updates and enhancements to our tested drug list are made from time to time based on surveillance data from the Center for Forensic Science Research and Education (CFSRE) and clinical patient trends. A complete and up to date list of the analytes contained in each drug class can be found at the bottom of each report and in our online FAQ.
Categories:
Price:
$322
|
|
Drug Monitoring, Designer Opioids, Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$322
|
|
|
Description:
Designer Opioids are compounds designed to mimic the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. They are a part of a class of drugs known as Novel Psychoactive Substances (NPS). NPS can also be referred to as legal highs, spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. Individuals may be exposed to illicit fentanyl or analogs, designer opoids, stimulants, and benzodiazepines, or xylazine, knowingly, or unknowingly through counterfeit prescription drugs intended to mimic common drugs such as oxycodone, hydrocodone, and alprazolam, among others. Updates and enhancements to our tested drug list are made from time to time based on surveillance data from the Center for Forensic Science Research and Education (CFSRE) and clinical patient trends. A complete and up to date list of the analytes contained in each drug class can be found at the bottom of each report and in our online FAQ.
Categories:
Price:
$322
|
|
Drug Monitoring, Designer Stimulants, Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$322
|
|
|
Description:
Designer Stimulants are compounds designed to mimic the the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. They are a part of a class of drugs known as Novel Psychoactive Substances (NPS). NPS can also be referred to as legal highs, spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. Individuals may be exposed to illicit fentanyl or analogs, designer opoids, stimulants, and benzodiazepines, or xylazine, knowingly, or unknowingly through counterfeit prescription drugs intended to mimic common drugs such as oxycodone, hydrocodone, and alprazolam, among others. Updates and enhancements to our tested drug list are made from time to time based on surveillance data from the Center for Forensic Science Research and Education (CFSRE) and clinical patient trends. A complete and up to date list of the analytes contained in each drug class can be found at the bottom of each report and in our online FAQ.
Categories:
Price:
$322
|
|
Drug Monitoring, Eszopiclone, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Zopiclone is used to treat patients with insomnia. This test is used to detect the presence of the drug as a therapeutic drug monitoring and to aide clinicians with the drug's dosage effectiveness.
Categories:
Price:
$326
|
|
Drug Monitoring, Fentanyl, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Fentanyl is an opioid analgesic with a potency approximately 80 times that of morphine. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of fentanyl is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Fentanyl, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Fentanyl is an opioid analgesic with a potency approximately 80 times that of morphine. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of fentanyl is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Fentanyl, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Fentanyl is an opioid analgesic with a potency approximately 80 times that of morphine. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of fentanyl is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Gabapentin, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Gabapentin is used as an anticonvulsant in the management of neuropathic pain in adults and as adjunctive therapy in the treatment of partial seizures in patients with epilepsy. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of gabapentin is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Heroin Metabolite, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
6-Monoacetylmorphine is the primary metabolite of heroin. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of 6-Monoacetylmorphine is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Heroin Metabolite, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
6-Monoacetylmorphine is the primary metabolite of heroin. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of 6-Monoacetylmorphine is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Heroin Metabolite, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
6-Monoacetylmorphine is the primary metabolite of heroin. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of 6-Monoacetylmorphine is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Ketamine, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Ketamine is a potent dissociative anesthetic and hallucinogenic. Traditionally, used as a veterinary tranquilizer. Esketamine (Spravatoยฎ) Nasal Spray FDA-approved for Treatment Resistant Depression in Humans Depressive Symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. Misuse and abuse occur due to the desired detachment and hallucinogenic effects associated with Ketamine.The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Marijuana Metabolite, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
11-Nor-9-Carboxy-delta 9 -THC (THCCOOH) is commonly accepted as the primary urinary metabolite in man. Detection of this metabolite is indicative of exposure to marijuana. The test is a definitive assay using a specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of THCCOOH is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Marijuana Metabolite, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
11-Nor-9-Carboxy-delta 9-THC (THCCOOH) is commonly accepted as the primary urinary metabolite in man. Detection of this metabolite is indicative of exposure to marijuana. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of THCCOOH is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Marijuana Metabolite, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
11-Nor-9-Carboxy-delta 9 -THC (THCCOOH) is commonly accepted as the primary urinary metabolite in man. Detection of this metabolite is indicative of exposure to marijuana. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of THCCOOH is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, MDMA/MDA, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
3,4-Methylenedioxymethamphetamine (MDMA, aka Ecstasy, Molly) is a stimulant that is hallucinogenic in large does. The test is a definitive assay using a specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of MDMA is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, MDMA/MDA, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
3,4-Methylenedioxymethamphetamine (MDMA, aka Ecstasy, Molly) is a stimulant that is hallucinogenic in large does. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of MDMA is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, MDMA, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
3,4-Methylenedioxymethamphetamine (MDMA, aka Ecstasy, Molly) is a stimulant that is hallucinogenic in large does. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of MDMA is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Meperidine, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Meperidine is classified as a narcotic analgesic used to treat moderate to severe pain. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of meperidine is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Methadone Metabolite, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Methadone is prescribed to patients for the alleviation of opioid addiction withdrawal symptoms and analgesic purposes. The methadone and metabolite test is a definitive drug assay using the liquid chromatography/mass spectrometry (LC/MS-MS) method of analysis. Therapeutic urine drug monitoring of methadone and its metabolite EDDP is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Methadone Metabolite, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Methadone is prescribed to patients for the alleviation of opioid addiction withdrawal symptoms and analgesic purposes. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of methadone and its metabolite EDDP is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as quantitative values and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Methadone Metabolite, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Methadone is prescribed to patients for the alleviation of opioid addiction withdrawal symptoms and analgesic purposes. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screening tests are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) confirmation test. Therapeutic urine drug monitoring of methadone and its metabolite EDDP is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Methamphetamine D/L Isomers, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
This test measures the ratio of the D and L isomers of methamphetamine in urine. Methamphetamine isomers are biomarkers to identify which forms of methamphetamine are present. The test is a definitive drug assay using the liquid chromatography/mass spectrometry (LC/MS-MS) method of analysis. Methamphetamine is a stimulant drug of abuse as well as a prescription drug used to treat attention deficit hyperactivity disorders (ADHD) and obesity. Methamphetamine has two isomer forms (D and L). The L isomer is used in over-the-counter nasal decongestant products and is also a metabolite of the drug selegiline. The D isomer is used for prescription methamphetamine and is also a metabolite of the drug benzphetamine. Illicit methamphetamine formulations are primarily the D form. Approximately 62% of an oral dose is excreted with ~33% as unchanged drug and ~66% metabolites (including amphetamine) [1]. According to the American Association for Clinical Chemistry (AACC), testing drugs/drug metabolites is recommended and effective for detecting the use of relevant over-the-counter, prescribed, and nonprescribed drugs, and illicit substances in pain-management patients [2]. Laboratory testing is more effective than other physician tools for the detection of these substances in pain-management patients and is useful for routine monitoring of adherence. Instances where unchanged drug is detected, but metabolite(s) is not, may be indicative of drug added to the specimen after collection (eg, pill shaving, drug spiking) [2]. Note: No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as quantitative values and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose because the drug is extensively metabolized and excreted in the urine. References 1. Desoxynยฎ [package insert]. Deerfield, IL: Ovation Pharmaceuticals, Inc; 2007. 2. AACC. Using clinical laboratory tests to monitor drug therapy in pain management patients. November 2017. https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Pain-Management/LMPGPain-Management20171220.pdf. Accessed November 21, 2019.
Categories:
Price:
$326
|
|
Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Methylphenidate is a mild CNS stimulant used to control symptoms of attention deficit hyperactivity disorder (ADHD) in adults and children. Ritalin acid is the metabolite of methylphenidate, and its detection is indicative of ingestion of methylphenidate. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of methylphenidate is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Mitragynine, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Monitoring of Mitragynine in urine, the results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.
Categories:
Price:
$326
|
|
Drug Monitoring, Mitragynine, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Monitoring of Mitragynine in urine, the results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.
Categories:
Price:
$446
|
|
Drug Monitoring, Naltrexone, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Naltrexone (opioid antagonist) is used to treat alcohol and opioid dependence. This new test provides an option for compliance monitoring for naltrexone use.
Categories:
Price:
$326
|
|
Drug Monitoring, Novel Psychoactive Substances (NPS), Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$357
|
|
|
Description:
Novel psychoactive substances (NPS) are compounds designed to mimic the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. NPS can also be referred to as legal highs, Spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. Individuals may be exposed to illicit fentanyl or analogs, designer opioids, stimulants, and benzodiazepines, or xylazine, knowingly, or unknowingly through counterfeit prescription drugs intended to mimic common drugs such as oxycodone, hydrocodone, and alprazolam, among others. Updates and enhancements to our tested drug list are made from time to time based on surveillance data from the Center for Forensic Science Research and Education (CFSRE) and clinical patient trends. A complete and up to date list of the analytes contained in each drug class can be found at the bottom of each report and in our online FAQ.
Categories:
Price:
$357
|
|
Drug Monitoring, Opiates Expanded, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$353
|
|
|
Description:
Opiates possess exceptional analgesic properties and have become the mainstay of pain management therapies. Being both psychologically and physically addictive, the monitoring of opiate use and abuse is a major component of any treatment program. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the opiates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$353
|
|
Drug Monitoring, Opiates, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Opiates possess analgesic properties and have become the mainstay of pain management therapies. Being both psychologically and physically addictive, the monitoring of opiate use and abuse is a major component of any treatment program. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of the opiates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Opiates, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Opiates possess exceptional analgesic properties and have become the mainstay of pain management therapies. Being both psychologically and physically addictive, the monitoring of opiate use and abuse is a major component of any treatment program. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the opiates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Opioids Panel, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$1781
|
|
|
Description:
Monitoring of parent compounds and their metabolites in urine. The results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.
Categories:
Price:
$1781
|
|
Drug Monitoring, Opioids Panel, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$539
|
|
|
Description:
Monitoring of parent compounds and their metabolites in urine. The results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.
Categories:
Price:
$539
|
